Pharmaceutical

Galapagos enters deal to boost decentralised CAR-T therapy production

Galapagos has signed a partnership with Blood Centers of America to expedite decentralised production of CAR-T cell therapies across the US.

May 19, 2024 - 04:00
Galapagos enters deal to boost decentralised CAR-T therapy production
Galapagos has signed a partnership with Blood Centers of America to expedite decentralised production of CAR-T cell therapies across the US.
Read the original article

Tags:

Previous Article

Erasca trims workforce and pipeline to focus on KRAS and molecular glues

Next Article

FDA grants breakthrough therapy status for Nuvalent’s NVL-655

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: The FDA needs a risk evaluation and mitigation strategy for Alzheimer’s drug lecanemab

Opinion: The FDA needs a risk evaluation and mitigation...

Jun 16, 2023

Opinion: Three ways to test medical AI for safety

Opinion: Three ways to test medical AI for safety

May 23, 2023

STAT+: Immunogen ovarian cancer drug shown to extend patients’ lives

STAT+: Immunogen ovarian cancer drug shown to extend pa...

May 3, 2023